SEC Form 4 · accession 0001571049-16-011469
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BFI Co., LLC
10% Owner
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 9:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Feb 1, 2016 | C | 28,000 | — | A | 78,000 | D | |
| Class A Common StockF1,F2 | Feb 1, 2016 | S | 4,000 | $33.46 | D | 74,000 | D | |
| Class A Common StockF1,F3 | Feb 2, 2016 | S | 4,000 | $33.44 | D | 70,000 | D | |
| Class A Common StockF1,F4 | Feb 3, 2016 | S | 4,000 | $33.26 | D | 66,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1 | — | Feb 1, 2016 | C | 28,000 | D | — | — | Class A Common Stock | 28,000 | 20,899,811 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.66 to $33.99, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.51 to $33.82, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.77 to $33.77, inclusive.